Key result
TEVAR shows comparable long-term mortality to conservative therapy for thoracic aortic aneurysms and dissections.
Why the study?
The immediate and long-term results of thoracic aortic endovascular repair compared with conservative therapy for thoracic aortic aneurysms and dissections needed to be studied.
Does TEVAR reduce mortality and morbidity compared to conservative therapy in patients with thoracic aortic aneurysms and dissections?
Cohort (n=80)
Does TEVAR reduce mortality and morbidity compared to conservative therapy in patients with thoracic aortic aneurysms and dissections?
Answers are grounded in this paper and cite their sources.
TEVAR demonstrates comparable short- and long-term clinical results to conservative therapy for uncomplicated thoracic aortic aneurysms and dissections, though it may promote more positive aortic remodeling.
Objective. To study the immediate and long-term results of thoracic aortic endovascular repair (TEVAR) and conservative therapy for thoracic aortic aneurysms and dissections. Material and methods. We analyzed the results (n=80) of TEVAR and conservative therapy for thoracic aortic dissection and aneurysms. TEVAR was performed in 52 patients, conservative therapy — in 28 patients. Patients with dissections comprised 69% (n=36) and 57% (n=16), respectively. Mean follow-up period was 2.7±0.3 years. Results. There were no significant differences in mortality and morbidity. In-hospital mortality was absent in both groups; 30-day mortality was 2% (n=1) and 4% (n=1), respectively. Long-term mortality rates were also comparable (12% (n=6) and 22% (n=6), respectively). No significant difference was found. Cumulative freedom from all endoleaks was 92% (95% CI 0.795—0.98), from dSINE — 96% (95% CI 0.80—0.986), from stent-graft migration and aneurysm expansion — 100%. Analysis of rates after TEVAR depending on thoracic aortic lesion showed that 30-day survival rate was 94% in the aneurysm group and 100% in the aortic dissection group (p=0.48). Subsequently, survival rate after TEVAR for aneurysms was 94% until three-year follow-up. After TEVAR for aortic dissections, 12-month survival rate was 89%, 3-year survival — 86%. Conclusion. Endovascular repair for thoracic aortic aneurysms and dissections is highly effective in early and long-term period. Compared to conservative therapy of uncomplicated aortic lesions, TEVAR demonstrates comparable short- and long-term clinical results. Despite the lack of significant difference in the outcomes, the percentage of positive aortic remodeling is higher after TEVAR. This trend suggests more favorable long-term outcomes, possible statistical difference in long-term period and necessary further study of this issue.
No takes yet. Share an insight, caveat, or question.
Хафизов et al. (2024) conducted a cohort in Thoracic aortic aneurysms and dissections (n=80). Thoracic aortic endovascular repair (TEVAR) vs. Conservative therapy was evaluated on Long-term mortality. Thoracic aortic endovascular repair demonstrated comparable long-term mortality to conservative therapy for thoracic aortic aneurysms and dissections.
Synapse has enriched 10 related papers. Consider them for comparative context: